Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Clinical Relevance of MYD88 L265P Mutation and Interleukin-10 Level in Cerebrospinal Fluid of Patients with Both Newly Diagnosed and Relapsed Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System

Blood (2019) 134 (Supplement_1): 4114.

https://doi.org/10.1182/blood-2019-128298

Published: 2019

Journal Articles

Hemophagocytic Lymphohistiocytosis: A Single Institution Experience

Poornima Ramadas, MBBS, Jennifer Leibovitch, MD, Teresa Gentile, MD PhD

Blood (2019) 134 (Supplement_1): 4877.

https://doi.org/10.1182/blood-2019-127517

Published: 2019

Journal Articles

Salvage Autologous Stem Cell Transplantation in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

Jaewon Hyung, MD, Jung Yong Hong, Dok Hyun Yoon, MD PhD, Kyoungmin Lee, MD, Shin Kim, RN, Chan-Sik Park, Jooryung Huh, MD PhD, Jin-Sook Ryu, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 5506.

https://doi.org/10.1182/blood.V130.Suppl_1.5506.5506

Published: 2017

Journal Articles

Thiotepa, Busulfan, and Cyclophosphamide and Busulfan, Cyclophosphamide, Etoposide As Autologous Stem Cell Transplantation Conditioning Regimen in Primary Central Nervous System Lymphoma

Jaewon Hyung, MD, Jung Yong Hong, Dok Hyun Yoon, MD PhD, Kyoungmin Lee, MD, Shin Kim, RN, Chan-Sik Park, Jooryung Huh, MD PhD, Jin-Sook Ryu, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 3300.

https://doi.org/10.1182/blood.V130.Suppl_1.3300.3300

Published: 2017

Journal Articles

A New Prognostic Scoring System to Predict Disease Progression and Mortality in Patients with Newly Diagnosed Primary CNS Lymphoma

Chia-Jen Liu, MD PhD, Chia-Hsin Lin, MD, Ying-Chung Hong, MD, Ching-Fen Yang, MD, Huai-Che Yang, MD, Li-Yu Fay, MD, Chiu-Mei Yeh, MS, Jyh-Pyng Gau, MD, Yuan-Bin Yu, MD, Tzeon-Jye Chiou, MD, Jin-Hwang Liu, MD PhD, Yao-Chung Liu, MD, Chung-Jen Teng, MD

Blood (2017) 130 (Supplement 1): 2858.

https://doi.org/10.1182/blood.V130.Suppl_1.2858.2858

Published: 2017

Journal Articles

Autologous Stem Cell Transplantation with Thiotepa, Busulfan, and Cyclophosphamide Conditioning in Patients with Primary Central Nervous System Lymphoma: A Remarkable Outcome Form Single-Center Experience

Seyoung Seo, Jung Yong Hong, Dok Hyun Yoon, Jeong Hoon Kim, Young Hyun Cho, Chan-Sik Park, Jooryung Huh, Kyung Won Kim, Cheolwon Suh

Blood (2016) 128 (22): 3462.

https://doi.org/10.1182/blood.V128.22.3462.3462

Published: 2016

Journal Articles

Bing-Neel Syndrome at Diagnosis of Waldenstrom: An Extremely Rare Case Report

Dionisios Stoumbos, MD, Ioannis Patsias, MD, Evaggelos Asmanis, MD, Evangelia Eleni Christaki, MD, Katsiva Vailiki, MD, Anna Tasidou, MD, Marie-Christine Kyrtsonis, MD, Panagiotis Repousis, MD, Maria Kotsopoulou, MD

Blood (2015) 126 (23): 5065.

https://doi.org/10.1182/blood.V126.23.5065.5065

Published: 2015

Journal Articles

Clinical Characteristics and Outcomes of Patients with Hodgkin Lymphoma with Central Nervous System Involvement: An International Multicenter Collaboration

Chan Yoon Cheah, MBBS DMedSc, Paul J Broeckelmann, MD, Alison J Moskowitz, MD, Andreas Engert, MD, Mats Jerkeman, MD PhD, Tarec Christoffer El-Galaly, Julie Vose, Diego Villa, MDMPH, Joseph M. Connors, MD, Tatyana Feldman, MD, Dai Chihara, MD PhD, Chelsea C Pinnix, MDPhD, Sarah A Milgrom, MD, Bouthaina S. Dabaja, MD, Yasuhiro Oki, MD, Michelle A. Fanale, MD

Blood (2015) 126 (23): 3865.

https://doi.org/10.1182/blood.V126.23.3865.3865

Published: 2015

Journal Articles

Combination of Rituximab with Chemotherapy Improved Outcome of Newly Diagnosed Primary CNS Lymphoma: A Retrospective Study of 209 Unselected Patients Referred to a Single Institution

Herve Ghesquieres, MD PhD, Celine Segura-Ferlay, MS, Gaelle Fossard, MD, Francois Ducray, MD PhD, Violaine Safar, MD, Philippe Rey, MD, Emmanuelle Nicolas-Virelizier, MD, Catherine Sebban, MD, Amine Belhabri, MD, Pierre Biron, MD, Emmanuel Jouanneau, MD PhD, David Meyronnet, MD PhD, Catherine Chassagne-Clement, MD, Jerome Honnorat, MD PhD, Jean-Yves Blay, MD PhD

Blood (2015) 126 (23): 1544.

https://doi.org/10.1182/blood.V126.23.1544.1544

Published: 2015

Journal Articles

Updated Results Confirm Favorable Outcome of Immunocompetent Patients with Primary CNS Lymphoma Treated By C5R Protocol in Combination with Intravenous Rituximab and Intrathecal Liposomal Cytarabine: A Multicentric Prospective Phase 2 Study of the Lymphoma Study Association (LYSA)

Herve Ghesquieres, MD PhD, Herve Tilly, MD PhD, Anne Sonet, MD, Jehan Dupuis, MD, Alexia Schwartzmann, Emmanuelle Nicolas-Virelizier, MD, Marc Andre, MD PhD, Fabienne Trullemans, MD, Emmanuel Fleck, MD, Sami Boussetta, Franck Morschhauser, MD PhD, Jean-Yves Blay, MD PhD

Blood (2014) 124 (21): 3060.

https://doi.org/10.1182/blood.V124.21.3060.3060

Published: 2014

Journal Articles

Increased Risk of Venous Thromboembolism in Primary Central Nervous System Lymphoma Patients Undergoing Therapy

Gayathri Ravi, MD, Brenda Cooper, MD, Erica L Campagnaro, MD, Basem M. William, MD, Richard J. Creger, Pharm D, Stanton L. Gerson, Marcos De Lima, MD, Hillard M. Lazarus, MD, Paolo Caimi, MD

Blood (2014) 124 (21): 5431.

https://doi.org/10.1182/blood.V124.21.5431.5431

Published: 2014

Journal Articles

Myelomatous Involvement Of The Central Nervous System: Mayo Clinic Experience

Jonas Paludo, MD, Utkarsh Painuly, MD, Shaji Kumar, MD, Francis Buadi, MD, Suzanne R Hayman, MD, Martha Q. Lacy, MD, Angela Dispenzieri, MD, John A. Lust, MD, PhD, David Dingli, M.D., Ph.D., Arleigh McCurdy, MD, Stephen J. Russell, MD, PhD, Nelson Leung, MD, Steven R Zeldenrust, MD, PhD, Vincent Rajkumar, MD, Morie A Gertz, M.D., Robert Kyle, MD, MACP, Prashant Kapoor, MD

Blood (2013) 122 (21): 3119.

https://doi.org/10.1182/blood.V122.21.3119.3119

Published: 2013

Journal Articles

Multicenter Analysis Of Primary Central Nervous System Lymphoma: Patient Characteristics, Treatment Patterns and Survival

Reem Karmali, MD, Michael De Vita, MD, Adam M. Petrich, MD, Chadi Nabhan, MD, FACP, Kimberly Kruczek, DO, Jeffrey Raizer, MD, Daniel McFarland, DO, David Peace, MD, Rimas Lukas, MD, Sanjib Basu, PhD, Stephanie A. Gregory, MD, Parameswaran Venugopal, MD

Blood (2013) 122 (21): 1803.

https://doi.org/10.1182/blood.V122.21.1803.1803

Published: 2013

Journal Articles

Early Response to Methotrexate, Vincristine and Procarbazine Chemotherapy-Adapted Strategy for Primary CNS Lymphoma: Omitted Radiotherapy for Patients Achieving Complete Response in Interim Analysis.

Yu Ri Kim, Se Hoon Kim, Jong Hee Chang, Chang-Ok Suh, Soo Jeong Kim, MD, yun Deok Kim, Doh Yu Hwang, MD, Ji Eun Jang, Shin Young Hyun, June-Won Cheong, Yoo-Hong Min, Jin Seok Kim

Blood (2012) 120 (21): 2719.

https://doi.org/10.1182/blood.V120.21.2719.2719

Published: 2012

Journal Articles

A Multicentric Prospective Phase 2 Study of Intravenous Rituximab and Intrathecal Liposomal Cytarabine in Combination with C5R Protocol Followed by Brain Radiotherapy for Immunocompetent Patients with Primary CNS Lymphoma: A Lymphoma Study Association (LYSA) Trial

Herve Ghesquieres, MD, PhD, Herve Tilly, MD, Anne Sonet, MD, Jehan Dupuis, MD, Alexia Schwartzmann, Emmanuelle Nicolas-Virelizier, MD, Marc Andre, MD, Fabienne Trullemans, MD, Emmanuel Fleck, MD, Sami Boussetta, Franck Morschhauser, MD, PhD, Jean-Yves Blay, MD, PhD

Blood (2012) 120 (21): 796.

https://doi.org/10.1182/blood.V120.21.796.796

Published: 2012

Journal Articles

First-Line Treatment and Outcome of Elderly Patients with Primary Central Nervous System Lymphoma (PCNSL) – A Systematic Review and Individual Patient Data Meta-Analysis

Blood (2012) 120 (21): 3655.

https://doi.org/10.1182/blood.V120.21.3655.3655

Published: 2012

Journal Articles

Primary Central Nervous System Lymphoma (PCNSL) in Immunocompetent Patients: An Analysis of Prognostic Factors and Treatment Strategies

Daniel C McFarland, D.O., Stephanie A. Gregory, MD, Yan Li, Youping Deng, Parameswaran Venugopal, MD

Blood (2011) 118 (21): 4955.

https://doi.org/10.1182/blood.V118.21.4955.4955

Published: 2011

Journal Articles

Demylinating Peripheral Neuropathy and Lymphoplasmacytic Lymphoma

Carol Ann Huff, MD, Vinay Chaudhry, Charlotte Sumner, David Cornblath

Blood (2010) 116 (21): 5090.

https://doi.org/10.1182/blood.V116.21.5090.5090

Published: 2010

Journal Articles

Spurious pleocytosis

Blood (2010) 116 (5): 678.

https://doi.org/10.1182/blood-2009-10-245720

Published: 2010

Journal Articles

“Lymphomatous and Leukemic Meningitis – Patterns of Cytomorphology and Value of MRI and Protein Analysis”.

Herwig Matthias Strik, Christina Perske, Peter Proemmel, Ingelore Nagel, Holger Nagel

Blood (2009) 114 (22): 5011.

https://doi.org/10.1182/blood.V114.22.5011.5011

Published: 2009

NARROW

Clinical Relevance of MYD88 L265P Mutation and Interleukin-10 Level in Cerebrospinal Fluid of Patients with Both Newly Diagnosed and Relapsed Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System

Hemophagocytic Lymphohistiocytosis: A Single Institution Experience

Salvage Autologous Stem Cell Transplantation in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

Thiotepa, Busulfan, and Cyclophosphamide and Busulfan, Cyclophosphamide, Etoposide As Autologous Stem Cell Transplantation Conditioning Regimen in Primary Central Nervous System Lymphoma

A New Prognostic Scoring System to Predict Disease Progression and Mortality in Patients with Newly Diagnosed Primary CNS Lymphoma

Autologous Stem Cell Transplantation with Thiotepa, Busulfan, and Cyclophosphamide Conditioning in Patients with Primary Central Nervous System Lymphoma: A Remarkable Outcome Form Single-Center Experience

Bing-Neel Syndrome at Diagnosis of Waldenstrom: An Extremely Rare Case Report

Clinical Characteristics and Outcomes of Patients with Hodgkin Lymphoma with Central Nervous System Involvement: An International Multicenter Collaboration

Combination of Rituximab with Chemotherapy Improved Outcome of Newly Diagnosed Primary CNS Lymphoma: A Retrospective Study of 209 Unselected Patients Referred to a Single Institution

Updated Results Confirm Favorable Outcome of Immunocompetent Patients with Primary CNS Lymphoma Treated By C5R Protocol in Combination with Intravenous Rituximab and Intrathecal Liposomal Cytarabine: A Multicentric Prospective Phase 2 Study of the Lymphoma Study Association (LYSA)

Increased Risk of Venous Thromboembolism in Primary Central Nervous System Lymphoma Patients Undergoing Therapy

Myelomatous Involvement Of The Central Nervous System: Mayo Clinic Experience

Multicenter Analysis Of Primary Central Nervous System Lymphoma: Patient Characteristics, Treatment Patterns and Survival

Early Response to Methotrexate, Vincristine and Procarbazine Chemotherapy-Adapted Strategy for Primary CNS Lymphoma: Omitted Radiotherapy for Patients Achieving Complete Response in Interim Analysis.

A Multicentric Prospective Phase 2 Study of Intravenous Rituximab and Intrathecal Liposomal Cytarabine in Combination with C5R Protocol Followed by Brain Radiotherapy for Immunocompetent Patients with Primary CNS Lymphoma: A Lymphoma Study Association (LYSA) Trial

First-Line Treatment and Outcome of Elderly Patients with Primary Central Nervous System Lymphoma (PCNSL) – A Systematic Review and Individual Patient Data Meta-Analysis

Primary Central Nervous System Lymphoma (PCNSL) in Immunocompetent Patients: An Analysis of Prognostic Factors and Treatment Strategies

Demylinating Peripheral Neuropathy and Lymphoplasmacytic Lymphoma

Spurious pleocytosis

“Lymphomatous and Leukemic Meningitis – Patterns of Cytomorphology and Value of MRI and Protein Analysis”.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only